Cargando…
EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the β-catenin/E-cadherin pathway
Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 (EBP50) has previously been demonstrated to be associated with the malignant transformation of numerous types of human cancer. The aim of the present study was to investigate the effect of EBP50 overexpression on pancreatic cancer and the underlyi...
Autores principales: | JI, MENGYAO, FAN, DIKUN, YUAN, LEI, ZHANG, YUNTING, DONG, WEIGUO, PENG, XIULAN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578050/ https://www.ncbi.nlm.nih.gov/pubmed/26622484 http://dx.doi.org/10.3892/etm.2015.2684 |
Ejemplares similares
-
EBP50 regulates the apoptosis of pancreatic cancer cells by decreasing the expression levels of Bcl-2
por: JI, MENGYAO, et al.
Publicado: (2014) -
Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex
por: Jiang, Yayun, et al.
Publicado: (2017) -
NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway–Driven Intestinal Neoplasia()
por: Georgescu, Maria-Magdalena, et al.
Publicado: (2016) -
E-Cadherin/β-Catenin Complex and the Epithelial Barrier
por: Tian, Xinrui, et al.
Publicado: (2011) -
The Potential Involvement of E-cadherin and β-catenins in Meningioma
por: Zhou, Keiyu, et al.
Publicado: (2010)